Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Authors
Keywords
-
Journal
CIRCULATION
Volume 148, Issue 19, Pages 1445-1454
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-09-08
DOI
10.1161/circulationaha.123.065614
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race
- (2021) Lesley A. Inker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge
- (2020) Giuseppe Lippi et al. International Journal of Stroke
- Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
- (2020) John W. Stanifer et al. CIRCULATION
- Epidemiology of Atrial Fibrillation in the 21st Century
- (2020) Jelena Kornej et al. CIRCULATION RESEARCH
- Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease
- (2020) Wern Yew Ding et al. CARDIOVASCULAR RESEARCH
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Performance of ICD-10-CM Diagnosis Codes for Identifying Acute Ischemic Stroke in a National Health Insurance Claims Database
- (2020) Meng-Tsang Hsieh et al. Clinical Epidemiology
- Using propensity scores to estimate effects of treatment initiation decisions: State of the science
- (2020) Michael Webster‐Clark et al. STATISTICS IN MEDICINE
- Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
- (2020) Michele Magnocavallo et al. Journal of Clinical Medicine
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Anticoagulation in Patients with Advanced Chronic Kidney Disease: Walking the Fine Line between Benefit and Harm
- (2019) Januvi Jegatheswaran et al. CANADIAN JOURNAL OF CARDIOLOGY
- Trends and Factors Associated With Concordance Between International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification Codes and Stroke Clinical Diagnoses
- (2019) Tiffany E. Chang et al. STROKE
- Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study
- (2019) Julio A. Lamprea‐Montealegre et al. Journal of the American Heart Association
- Characterizing the Safety Profile of Apixaban Versus Warfarin in Moderate to Severe Chronic Kidney Disease at a Veterans Affairs Hospital
- (2019) Kyle Herndon et al. ANNALS OF PHARMACOTHERAPY
- Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
- (2018) Joseph H. Schafer et al. ANNALS OF PHARMACOTHERAPY
- Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States
- (2018) Konstantinos C. Siontis et al. CIRCULATION
- Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2018) Mintu P Turakhia et al. EUROPEAN HEART JOURNAL
- Apixaban Dosing in Chronic Kidney Disease
- (2017) Donald F. Brophy JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reply
- (2017) Marco Proietti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment
- (2017) Brooke E. Stanton et al. PHARMACOTHERAPY
- Practical recommendations for reporting Fine-Gray model analyses for competing risk data
- (2017) Peter C. Austin et al. STATISTICS IN MEDICINE
- OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism
- (2016) A. Young et al. THROMBOSIS RESEARCH
- Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
- (2015) G. Agnelli et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
- (2015) M. Jun et al. BMJ-British Medical Journal
- The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
- (2015) M. Jun et al. BMJ-British Medical Journal
- Optum Labs: Building A Novel Node In The Learning Health Care System
- (2014) Paul J. Wallace et al. HEALTH AFFAIRS
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Subclinical Atrial Fibrillation and the Risk of Stroke
- (2012) Jeff S. Healey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
- (2010) John W. Eikelboom et al. AMERICAN HEART JOURNAL
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
- (2010) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
- (2009) W. Ananthapanyasut et al. Clinical Journal of the American Society of Nephrology
- Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals
- (2009) Stanley Xu et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search